| 摘要 |
The proposed compositions of fatty acids comprise at least 80 % by weight of omega-3-unsaturated fatty acids, their salts or derivatives, (all-Z)-5,8,11,14,17-eicosapentaenoic acid (EPA) and (all-Z)-4,7,10,13,16,19-docosahexaenoic acid constituting at least 75 % by weight of the total fatty acids. The compositions may be used in the curative or prophylatic treatment of multiple risk factors for cardiovascular diseases.
|
